insulin


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

in·su·lin

 (ĭn′sə-lĭn)
n.
1. A polypeptide hormone that is secreted by the beta cells of the islets of Langerhans in the pancreas and functions in the regulation of carbohydrate and fat metabolism, especially the conversion of glucose to glycogen, which lowers the blood glucose level. It consists of two linked polypeptide chains called A and B.
2. Any of various pharmaceutical preparations containing this hormone or a close chemical analog, derived from the pancreas of certain animals or produced through genetic engineering and used in the medical treatment and management of type 1 and type 2 diabetes.

[New Latin īnsula, island (of Langerhans) (from Latin, island) + -in.]

insulin

(ˈɪnsjʊlɪn)
n
(Biology) a protein hormone, secreted in the pancreas by the islets of Langerhans, that controls the concentration of glucose in the blood. Insulin deficiency results in diabetes mellitus
[C20: from New Latin insula islet (of the pancreas) + -in]

in•su•lin

(ˈɪn sə lɪn, ˈɪns yə-)

n.
1. a hormone, produced by the beta cells of the islets of Langerhans of the pancreas, that regulates the metabolism of glucose and other nutrients.
2. any of several commercial preparations of this substance, each absorbed into the body at a particular rate: used for treating diabetes.
[1910–15; < Latin insul(a) island (alluding to the islets of Langerhans) + -in1]

in·su·lin

(ĭn′sə-lĭn)
1. A hormone produced in the pancreas that acts to regulate the amount of sugar in the blood by causing cells, especially liver and muscle cells, to absorb glucose from the bloodstream.
2. A drug containing this hormone, obtained from the pancreas of animals or produced synthetically and used in treating diabetes.

insulin

A hormone that lowers the level of glucose in blood. Insulin is produced in the pancreas. See pancreatic islets.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.insulin - hormone secreted by the isles of Langerhans in the pancreasinsulin - hormone secreted by the isles of Langerhans in the pancreas; regulates storage of glycogen in the liver and accelerates oxidation of sugar in cells
endocrine, hormone, internal secretion - the secretion of an endocrine gland that is transmitted by the blood to the tissue on which it has a specific effect
Lente Iletin, Lente Insulin - trade names for forms of insulin that are used to treat diabetes mellitus
Humulin, recombinant human insulin - a form of insulin (trade name Humulin) made from recombinant DNA that is identical to human insulin; used to treat diabetics who are allergic to preparations made from beef or pork insulin
hypoglycaemic agent, hypoglycemic agent - any of various agents that decrease the level of glucose in the blood and are used in the treatment of diabetes mellitus
Translations
insulien
инсулин
insulina
inzulíninzulin
insulin
insulino
insuliin
انسولین
insuliini
inzulin
inzulin
insulin
insúlín
インシュリンインスリン
인슐린
insulinum
insulinas
insulīns
ഇന്‍സുലിന്‍
insulină
inzulín
insulin
инсулин
insulin
สารชนิดหนึ่งสกัดจากตับอ่อนอินซูลิน
інсулін
جزیرین
chất insulininsulin

insulin

[ˈɪnsjʊlɪn] Ninsulina f

insulin

[ˈɪnsjʊlɪn] ninsuline f
to be on insulin → être sous insuline

insulin

nInsulin nt

insulin

[ˈɪnsjʊlɪn] ninsulina
insulin injection → iniezione f d'insulina

insulin

(ˈinsjulin) noun
a substance used in the treatment of the disease diabetes.

insulin

أَنْسُولِيـنٌ inzulín insulin Insulin ινσουλίνη insulina insuliini insuline inzulin insulina インシュリン 인슐린 insuline insulin insulina insulina инсулин insulin สารชนิดหนึ่งสกัดจากตับอ่อน ensülin chất insulin 胰岛素

in·su·lin

[MIM*176730]
n. insulina. hormona secretada en el páncreas;
___ dependentinsulinodependiente.

insulin

n insulina; basal — insulina basal; human — insulina humana; — analogue análogo de la insulina; — aspart insulina aspart, insulina asparta (INN); — detemir insulina detemir; — glargine insulina glargina; — gluli-sine insulina glulisina; — lispro insulina lispro; intermediate-acting — insulina de acción intermedia; long-acting — insulina de acción prolongada; NPH — insulina NPH; pre-mixed — insulina premezclada; rapid-acting — insulina de acción rápida; rapid-acting — analogue análogo de insulina de acción rápida; recombinant — insulina recombinante; regular — insulina regular; to take — inyectarse insulina
References in periodicals archive ?
Heise, "Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review," Diabetes, Obesity and Metabolism, vol.
The Global Human Recombinant Insulin Market, by Product Type (Rapid-Acting Human Insulin, Short-Acting Human Insulin, Intermediate-Acting Human Insulin, Long-Acting Human Insulin, and Premixed Human Insulin), by Brand (Humalog, Novolog, Apidra, Humulin R, Novolin R, Humulin N, Novolin N, Levemir, Lantus, Humalog Mix, Novolog Mix, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) was valued US$ 27.4 billion in 2018, and is projected to exhibit a CAGR of 7.2% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.
This causes the impaired functioning of the pancreas that lead to an eventual decrease in insulin production over a period of time.
While the intent of this action is to ease the approval pathway for lower-cost biosimilar products, it creates a perverse incentive that could delay approval of generic insulin. FDAs new guidance effectively creates an application termination cliff on March 23, 2020in which FDA will automatically reject generic insulin products that are in the approval pipeline during that time.
[UKPRwire, Mon May 20 2019] Global human insulin market Increasing population exposure to key risk factors leading to diabetes, technological advancements in insulin delivery devices, growth in the number of diabetic patients, and growing geriatric population are the factors driving the market growth.
[ClickPress, Fri May 17 2019] A new report titled " Smart Insulin Pens Market Assessment Covering Growth Factors and Upcoming Trends till 2027 End" has been included in the enormous research repository of Market Research Reports Search Engine (MRRSE) that compiles various facets of the Smart Insulin Pens market at a global level portraying a holistic analysis of the marketplace along with intelligence on key participants.
Despite starting patients on insulin, there still is increased mortality and morbidity in diabetic patients than in non-diabetic patients.
A cross sectional study was conducted on patients with both Type-1 and Type-2 diabetes presenting to diabetic out-patient clinics at Mayo Hospital and Services hospital, Lahore to assess the barriers regarding early initiation of insulin therapy.
Keywords: Type 1 diabetes, infants and toddlers, insulin administration, insulin injection technique.
To underscore this crucial issue, a series of sets of insulin and glucose profiles obtained with five timed blood samples (fasting, 1/2-hour, 1-hour, 2-hour, and 3-hour) obtained after a 75-gram glucose challenge, are presented.
Assessment of nurses' insulin injection practice is important to ensure the safe and effective use of insulin pens.
He had been using premix insulin 30 : 70 (Huminsulin 30/70, Lilly Frances S.A.S., 67640 Fegersheim, France) through HumaPen Ergo II (Eli Lilly and Company, Pharmaceutical Delivery System, Lilly Corporate Centre, Indianapolis, IN 46285, USA), 20 units before lunch and 6 units before dinner, to control his BSL for the last 12 years.